Icon

BYDUREON (nda022200)- (2MG/VIAL)

EXENATIDE SYNTHETIC ASTRAZENECA AB
2MG/VIAL
No No
2030-May-26 Expired
None 2015-Jan-27
None No
BYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
0 0 0
Total Other Developers 6
Drugs with Suitability No
2MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.